AbbVie begins trials of COVID-19 antibody therapyAbbVie is to begin clinical development of an antibody designed to neutralise the SARS-CoV-2 coronavirus after licensing the Share XAbbVie begins trials of COVID-19 antibody therapyhttps://pharmaphorum.com/news/abbvie-licenses-in-covid-19-antibody-therapy-from-harbour-utrecht-uni/
